Biosimilars Market, Size, Revenue, Insights to Reach USD 143.97 Billion by 2032 | IMR Global Biosimilars Market Size Was Valued at USD 34.01 Billion in 2023 and is Projected to Reach USD 143.97 Billion by 2032, Growing at a CAGR of 17.39% From 2024-2032.
Biosimilars are biologic medical products highly similar to already approved reference biologics, offering comparable safety, efficacy, and quality. Unlike generic drugs, which are identical chemical copies of branded drugs,...
English